4.6 Article

Continuum of Vasodilator Stress From Rest to Contrast Medium to Adenosine Hyperemia for Fractional Flow Reserve Assessment

期刊

JACC-CARDIOVASCULAR INTERVENTIONS
卷 9, 期 8, 页码 757-767

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcin.2015.12.273

关键词

adenosine; contrast medium; fractional flow reserve; hyperemia; instantaneous wave-free ratio

资金

  1. Weatherhead PET Center for Preventing and Reversing Atherosclerosis
  2. Boston Scientific
  3. Abbott Vascular
  4. Medtronic
  5. Cordis Johnson Johnson
  6. AstraZeneca
  7. Merck Sharp Dohme
  8. St. Jude Medical
  9. Volcano Corporation
  10. MRC [MR/N003403/1] Funding Source: UKRI
  11. British Heart Foundation [PG/14/97/31263] Funding Source: researchfish
  12. Medical Research Council [MR/N003403/1] Funding Source: researchfish

向作者/读者索取更多资源

OBJECTIVES This study compared the diagnostic performance with adenosine-derived fractional flow reserve (FFR) <= 0.8 of contrast-based FFR (cFFR), resting distal pressure (Pd)/aortic pressure (Pa), and the instantaneous wave-free ratio (iFR). BACKGROUND FFR objectively identifies lesions that benefit from medical therapy versus revascularization. However, FFR requires maximal vasodilation, usually achieved with adenosine. Radiographic contrast injection causes submaximal coronary hyperemia. Therefore, intracoronary contrast could provide an easy and inexpensive tool for predicting FFR. METHODS We recruited patients undergoing routine FFR assessment and made paired, repeated measurements of all physiology metrics (Pd/Pa, iFR, cFFR, and FFR). Contrast medium and dose were per local practice, as was the dose of intracoronary adenosine. Operators were encouraged to perform both intracoronary and intravenous adenosine assessments and a final drift check to assess wire calibration. A central core lab analyzed blinded pressure tracings in a standardized fashion. RESULTS A total of 763 subjects were enrolled from 12 international centers. Contrast volume was 8 +/- 2 ml per measurement, and 8 different contrast media were used. Repeated measurements of each metric showed a bias < 0.005, but a lower SD (less variability) for cFFR than resting indexes. Although Pd/Pa and iFR demonstrated equivalent performance against FFR <= 0.8 (78.5% vs. 79.9% accuracy; p = 0.78; area under the receiver-operating characteristic curve: 0.875 vs. 0.881; p = 0.35), cFFR improved both metrics (85.8% accuracy and 0.930 area; p < 0.001 for each) with an optimal binary threshold of 0.83. A hybrid decision-making strategy using cFFR required adenosine less often than when based on either Pd/Pa or iFR. CONCLUSIONS cFFR provides diagnostic performance superior to that of Pd/Pa or iFR for predicting FFR. For clinical scenarios or health care systems in which adenosine is contraindicated or prohibitively expensive, cFFR offers a universal technique to simplify invasive coronary physiological assessments. Yet FFR remains the reference standard for diagnostic certainty as even cFFR reached only similar to 85% agreement. (C) 2016 by the American College of Cardiology Foundation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据